Summary
Updated Aug 30, 2026
Steven L. Hoerter is President and CEO, Director of MBX Biosciences, Inc. (MBX). 9 SEC Form 4 filings on record going back to 2024, most recently on 4 August 2026. Most recent open-market trade: bought $265K of MBX on 20 October 2025. Lifetime open-market purchases: $265K.
Recent Transactions
3Every recent SEC Form 4 transaction Steven L. Hoerter has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Steven L. Hoerter files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Patrick J. Heron - $12.00M of MBX open-market activity in the last 12 months
- Salomon Azoulay - $2.72M of MBX open-market activity in the last 12 months
- P. Kent Hawryluk - $816K of MBX open-market activity in the last 12 months
- Leonard Reyno - $22K of CCCC open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Steven L. Hoerter?
Steven L. Hoerter is a corporate insider, tracked as President and CEO, Director of MBX Biosciences, Inc. (MBX). InsiderAlpha holds 9 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Steven L. Hoerter submitted recently?
3 primary Form 4 filings in the last 90 days, covering 2 companies.
Has Steven L. Hoerter been buying or selling stock?
Recorded transactions: 1 open-market purchase ($265K) and 0 open-market sales across all tracked filings.
Where can I see all of Steven L. Hoerter's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Steven L. Hoerter and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
